RXL:ARCA-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 44.93

Change

-0.47 (-1.04)%

Market Cap

USD 0.07B

Volume

3.50K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Health Care TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.06%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.82B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 8.38B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.69% 33% F 33% F
Dividend Return 1.69% 76% C+ 28% F
Total Return 0.01% 32% F 26% F
Trailing 12 Months  
Capital Gain -1.69% 33% F 33% F
Dividend Return 1.69% 76% C+ 28% F
Total Return 0.01% 32% F 26% F
Trailing 5 Years  
Capital Gain 40.08% 67% D+ 70% C-
Dividend Return 4.05% 66% D+ 10% F
Total Return 44.13% 67% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 12.22% 28% F 69% C-
Dividend Return 12.50% 28% F 65% D
Total Return 0.28% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.35% 97% N/A 34% F
Risk Adjusted Return 39.88% 67% D+ 54% F
Market Capitalization 0.07B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.